EP2586788

GENENTECH, INC.
Application Number
EP12178200A
Filing Date
Jul 8, 2008
Status
Revoked
Dec 16, 2022
Grant Date
Nov 29, 2017
External Links
Slate, Register

Biblio Summary

The patent EP2586788B1 was granted on Nov 29, 2017 by Genentech, Inc. The patent is currently Revoked.

The table below shows 9 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BAYER INTELLECTUAL PROPERTY GMBHAug 29, 2018ADMISSIBLE
DF-MP DORRIES FRANK-MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBAug 29, 2018ADMISSIBLE
MAIWALD GMBHAug 29, 2018ADMISSIBLE
MERCK SHARP & DOHME CORP.Aug 29, 2018ADMISSIBLE
OETKE, CORNELIAAug 29, 2018ADMISSIBLE
UCB BIOPHARMA SRLAug 29, 2018ADMISSIBLE
GLAXO GROUP LIMITEDAug 27, 2018ADMISSIBLE
GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBBAug 27, 2018ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBAug 24, 2018ADMISSIBLE

The table below shows the patents of Genentech, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2694072Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of UseAug 7, 20241
EP4108259Process For Concentration Of Antibodies And Therapeutic Products ThereofJan 3, 20241
EP3589661Adjuvant Treatment Of Her2-Positive Breast CancerNov 1, 20234

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents